Page last updated: 2024-08-22

mopidamol and Neoplasms

mopidamol has been researched along with Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrus, JL; Biddle, W; Horoszewicz, J; Leong, SS1
Cornell, CJ; Forcier, RJ; Forman, WB; Henderson, WG; Martin, JF; Rickles, FR; Van Eeckhout, JP; Zacharski, LR1
O'Donnell, MR; Slichter, SJ; Storb, R; Weiden, PL1
Ambrus, CM; Ambrus, JL; Gastpar, H1
Ambrus, CM; Ambrus, JL; Biddle, W; Gastpar, H; Horoszewicz, J; Huberman, E; Leong, S; Montagna, R1
Clark, RL1

Reviews

2 review(s) available for mopidamol and Neoplasms

ArticleYear
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
    American journal of clinical oncology, 1982, Volume: 5, Issue:6

    Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation

1982
Systemic cancer and the metastatic process.
    Cancer, 1979, Volume: 43, Issue:3

    Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Adhesion; Cell Membrane; Cell Transformation, Neoplastic; Humans; Macrophages; Mopidamol; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Platelet Aggregation

1979

Trials

1 trial(s) available for mopidamol and Neoplasms

ArticleYear
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
    American journal of clinical oncology, 1982, Volume: 5, Issue:6

    Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation

1982

Other Studies

4 other study(ies) available for mopidamol and Neoplasms

ArticleYear
Potentiation of the cell growth inhibitory effect of beta interferon by mopidamole.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1984, Volume: 177, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cell Division; Cell Line; Drug Synergism; Fibroblasts; Humans; Interferon Type I; Mopidamol; Neoplasms; Pyrimidines

1984
Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.
    Blood, 1982, Volume: 59, Issue:6

    Topics: Animals; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Fibrinogen; Fibrinolytic Agents; Kinetics; Mopidamol; Neoplasms; Phosphodiesterase Inhibitors; Platelet Count; Sulfinpyrazone; Warfarin

1982
Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: Animals; Blood Platelets; Female; Humans; Male; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Pentoxifylline; Platelet Aggregation; Pyrimidines; Rats; Transplantation, Heterologous

1982
Antimetastatic and antitumor effect of platelet aggregation inhibitors.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: Animals; Female; Humans; Male; Melanoma; Mice; Mopidamol; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Platelet Aggregation; Pyrimidines; Rats; Transplantation, Heterologous

1982